Activation of myeloid and endothelial cells by CD40L gene therapy supports T-cell expansion and migration into the tumor microenvironment

CD40 is an interesting target in cancer immunotherapy due to its ability to stimulate T-helper 1 immunity via maturation of dendritic cells and to drive M2 to M1 macrophage differentiation. Pancreatic cancer has a high M2 content that has shown responsive to anti-CD40 agonist therapy and CD40 may th...

Descripción completa

Detalles Bibliográficos
Autores principales: Eriksson, E, Moreno, R, Milenova, I, Liljenfeldt, L, Dieterich, L C, Christiansson, L, Karlsson, H, Ullenhag, G, Mangsbo, S M, Dimberg, A, Alemany, R, Loskog, A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5441514/
https://www.ncbi.nlm.nih.gov/pubmed/27906162
http://dx.doi.org/10.1038/gt.2016.80

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5441514/
https://www.ncbi.nlm.nih.gov/pubmed/27906162
http://dx.doi.org/10.1038/gt.2016.80

Ejemplares similares